Engel Law PLLC is investigating whether fair value to Livent shareholders will result from the proposed all-stock merger of equals between Livent Corp. (NYSE: LTHM) and Allkem (ASX:AKE), pursuant to which Allkem shareholders will own approximately 56% and Livent shareholders will own approximately 44% of a newly formed combined company.
The Firm’s investigation concerns:
(i) whether the Company’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction;
(ii) whether the merger consideration adequately compensates the Company’s shareholders; and
(iii) whether all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.